Your browser doesn't support javascript.
loading
Predicting Complications following Surgical Resection of Hepatocellular Carcinoma Using Newly Developed Neo-Glasgow Prognostic Score with ALBI Grade: Comparison of Open and Laparoscopic Surgery Cases.
Kaibori, Masaki; Hiraoka, Atsushi; Matsui, Kosuke; Matsushima, Hideyuki; Kosaka, Hisashi; Yamamoto, Hidekazu; Yamaguchi, Takashi; Yoshida, Katsunori; Sekimoto, Mitsugu.
Affiliation
  • Kaibori M; Department of Surgery, Kansai Medical University, Osaka 573-1191, Japan.
  • Hiraoka A; Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama 790-0024, Japan.
  • Matsui K; Department of Surgery, Kansai Medical University, Osaka 573-1191, Japan.
  • Matsushima H; Department of Surgery, Kansai Medical University, Osaka 573-1191, Japan.
  • Kosaka H; Department of Surgery, Kansai Medical University, Osaka 573-1191, Japan.
  • Yamamoto H; Department of Surgery, Kansai Medical University, Osaka 573-1191, Japan.
  • Yamaguchi T; Department of Gastroenterology and Hepatology, Kansai Medical University, Osaka 573-1191, Japan.
  • Yoshida K; Department of Gastroenterology and Hepatology, Kansai Medical University, Osaka 573-1191, Japan.
  • Sekimoto M; Department of Surgery, Kansai Medical University, Osaka 573-1191, Japan.
Cancers (Basel) ; 14(6)2022 Mar 09.
Article in En | MEDLINE | ID: mdl-35326554
ABSTRACT
Background/

Aim:

Nutritional assessment is known to be important for predicting prognosis in patients with malignant diseases. This study examined the usefulness of a prognostic predictive nutritional assessment tool for hepatocellular carcinoma (HCC) patients treated with surgical resection. Materials/

Methods:

HCC patients (n = 429) classified as Child−Pugh A who underwent an R0 resection between 2010 and 2020 were retrospectively analyzed (median age 73 years, males 326 (76.0%), Child−Pugh score 56 = 326103, single tumor 340 (79.2%), median tumor size 3.5 cm, openlaparoscopic = 304125). Glasgow prognostic score (GPS) and the newly developed neo-GPS method, which uses albuminbilirubin grade 1 instead of albumin, were evaluated to compare their usefulness for prognosis prediction.

Results:

Median survival time for patients with a GPS score of 0, 1, and 2 was 120, 51, and 20 months, respectively. As for neo-GPS, that for those with a score of 0, 1, and 2 was not applicable (NA), 53 months, and 35 months, respectively (each p < 0.001; c-index 0.556 and 0.611, respectively). Furthermore, median progression-free survival was 33, 22, and 9 months, and 41, 24, and 15 months, respectively (each p < 0.001; c-index 0.539 and 0.578, respectively). As compared to patients with a high GPS (≥1), those with a high neo-GPS (≥1) showed a greater rate of high Clavien−Dindo classification (≥3) (39.2% vs. 65.1%). A comparison of patients with a high GPS (≥1) with those with a high neo-GPS (≥1) showed no significant difference regarding frequency of open or laparoscopic hepatectomy (17.4% vs. 15.2%, p = 0.670; 44.7% vs. 43.2%, p = 0.831, respectively), while the frequency of high Clavien−Dindo classification (≥3) was lower in patients who underwent a laparoscopic hepatectomy (11.2% vs. 22.7%, p = 0.007).

Conclusion:

The present findings suggest that the newly developed neo-GPS based on ALBI grade is an effective prognostic nutritional assessment tool and can be used for prediction of postoperative complications.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: Publication country: CH / SUIZA / SUÍÇA / SWITZERLAND

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: Publication country: CH / SUIZA / SUÍÇA / SWITZERLAND